Trial NCT03672643

View at ClinicalTrials.gov 
Org. Study IDs: A8081067

Last trial update was posted on 2023-10-19

MeSH Interventions

Crizotinib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions

ALK or ROS1-positive NSCLC

Stopping Reasons

The trial is terminated based on business decision, not due to safety concerns or regulatory requirements.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID